Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Everything the market-wide feed shows by default: the rare events, plus management changes, restructurings, impairments, new debt and material agreements.

Date Company Event Filing
Processa Pharmaceuticals, Inc. PCSA Officer or director change Item 5.02 Form 8-K
Prologis, Inc. PLD Material agreement signed Item 1.01 Form 8-K
Prologis, Inc. PLD New debt or obligation Item 2.03 Form 8-K
QUANTA SERVICES, INC. PWR Material agreement signed Item 1.01 Form 8-K
RESIDEO TECHNOLOGIES, INC. REZI Material agreement signed Item 1.01 Form 8-K
RESIDEO TECHNOLOGIES, INC. REZI Acquisition or disposal completed Item 2.01 Form 8-K
RESIDEO TECHNOLOGIES, INC. REZI Shareholder rights changed Item 3.03 Form 8-K
RESIDEO TECHNOLOGIES, INC. REZI Officer or director change Item 5.02 Form 8-K
Rani Therapeutics Holdings, Inc. RANI Officer or director change Item 5.02 Form 8-K
SHF Holdings, Inc. SHFS Officer or director change Item 5.02 Form 8-K
SSR MINING INC. SSRM Material agreement signed Item 1.01 Form 8-K
SSR MINING INC. SSRM New debt or obligation Item 2.03 Form 8-K
STEEL DYNAMICS INC STLD Officer or director change Item 5.02 Form 8-K
Seagate Technology Holdings plc STX Annual report filed FY to 2026-07-03 Form 10-K
Seres Therapeutics, Inc. MCRB Material agreement signed Item 1.01 Form 8-K
Seres Therapeutics, Inc. MCRB Material agreement terminated Item 1.02 Form 8-K
Stagwell Inc STGW Officer or director change Item 5.02 Form 8-K
Streamex Corp. STEX Officer or director change Item 5.02 Form 8-K
Super League Enterprise, Inc. SLE Material agreement signed Item 1.01 Form 8-K
TELA Bio, Inc. TELA Officer or director change Item 5.02 Form 8-K
Theriva Biologics, Inc. TOVX Officer or director change Item 5.02 Form 8-K
UNIVERSAL CORP /VA/ UVV Officer or director change Item 5.02 Form 8-K
Waste Connections, Inc. WCN Material agreement signed Item 1.01 Form 8-K
Waste Connections, Inc. WCN New debt or obligation Item 2.03 Form 8-K
Wheels Up Experience Inc. UP Material agreement signed Item 1.01 Form 8-K
Wheels Up Experience Inc. UP New debt or obligation Item 2.03 Form 8-K
Z Squared Inc. ZSQR Material agreement signed Item 1.01 Form 8-K
Z Squared Inc. ZSQR Material agreement terminated Item 1.02 Form 8-K
iBio, Inc. IBIO Officer or director change Item 5.02 Form 8-K
AGCO CORP /DE AGCO Officer or director change Item 5.02 Form 8-K
AIR INDUSTRIES GROUP AIRI Material agreement signed Item 1.01 Form 8-K
AMAZE HOLDINGS, INC. AMZE Officer or director change Item 5.02 Form 8-K
AZZ INC AZZ Officer or director change Item 5.02 Form 8-K
Alkermes plc. ALKS Officer or director change Item 5.02 Form 8-K
Alzamend Neuro, Inc. ALZN Material agreement signed Item 1.01 Form 8-K
Alzamend Neuro, Inc. ALZN Delisting notice Item 3.01 Form 8-K
American Bitcoin Corp. ABTC Officer or director change Item 5.02 Form 8-K
Amneal Pharmaceuticals, Inc. AMRX Material agreement signed Item 1.01 Form 8-K
Armlogi Holding Corp. BTOC Officer or director change Item 5.02 Form 8-K
Atkore Inc. ATKR Material agreement signed Item 1.01 Form 8-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.